Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis.

The rate of occurrence of new distant metastasis for the patients with non-responsive vascular thrombi was higher than those with a vascular response, but such difference was not quite significant (25% vs 5.6%; p = 0.164).

also in 653 other papers